Search
Now showing items 1-8 of 8
Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure
(BMC, 2016)
Substantial attention and resources have been directed to improving outcomes of patients with critical illnesses, in particular sepsis, but all recent clinical trials testing various interventions or strategies have failed ...
Letter to editor: Clinical profile and predictors of in-hospital outcome in patients with heart failure
(ELSEVIER IRELAND LTD, 2011)
…
Association of right heart with CA-125 levels in patients with heart failure
(ELSEVIER IRELAND LTD, 2010)
…
Depression and heart failure
(ELSEVIER IRELAND LTD, 2012)
…
CA125 in heart failure: Implications for immunoinflammatory activity
(ELSEVIER IRELAND LTD, 2011)
…
Tumour biomarkers in heart failure: is there a role for CA-125?
(WILEY, 2011)
Tumour markers are used for the screening, diagnosis, and stratification of cancer disease. Recently, the potential role of some tumour markers has also been explored in the context of heart failure. These include CA-125, ...
Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
(WILEY, 2017)
Organ injury and impairment are commonly observed in patients with acute heart failure (AHF), and congestion is an essential pathophysiological mechanism of impaired organ function. Congestion is the predominant clinical ...
CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival
(ELSEVIER IRELAND LTD, 2010)
…